67 research outputs found
African American and Caucasian Perceptions and Attitudes Toward Colorectal Cancer Screening: A Qualitative Study
This study examined the attitudes held by both African Americans and Caucasians regarding colorectal cancer screening and the reasons why they avoid screenings even when clinically indicated by their physicians. Colorectal cancer (CRC) is one of the most common and easily preventable types of cancer in the United States. If diagnosed and treated early prior to metastasis, the five-year colorectal cancer survival rate is approximately 90%. However, many patients avoid screening procedures for colorectal cancer due to a number of reasons. Qualitative data was gathered from focus groups and found four major themes that emerged in both groups: (1) reported barriers to screening, (2) level of knowledge about CRC, (3) knowledge of risk factors for CRC, and (4) suggested strategies for improving CRC screening. African Americans and Caucasians reported differential concerns for each of those themes, including on physician vs. access issues (barriers), environmental vs. hereditary diseases (risk factors), community vs. physician-based interventions (strategies), and substantial differences with regard to CRC knowledge
A systematic review of the factors affecting the provision of social support from co-workers during the return-to-work process
Cerebrospinal Fluid Cortisol Mediates Brain-Derived Neurotrophic Factor Relationships to Mortality after Severe TBI: A Prospective Cohort Study
Distinct regulatory signaling mechanisms exist between cortisol and brain derived neurotrophic factor (BDNF) that may influence secondary injury cascades associated with traumatic brain injury (TBI) and predict outcome. We investigated concurrent CSF BDNF and cortisol relationships in 117 patients sampled days 0â6 after severe TBI while accounting for BDNF genetics and age. We also determined associations between CSF BDNF and cortisol with 6-month mortality. BDNF variants, rs6265 and rs7124442, were used to create a gene risk score (GRS) in reference to previously published hypothesized risk for mortality in âyounger patientsâ (<48 years) and hypothesized BDNF production/secretion capacity with these variants. Group based trajectory analysis (TRAJ) was used to create two cortisol groups (high and low trajectories). A Bayesian estimation approach informed the mediation models. Results show CSF BDNF predicted patient cortisol TRAJ group (P = 0.001). Also, GRS moderated BDNF associations with cortisol TRAJ group. Additionally, cortisol TRAJ predicted 6-month mortality (P = 0.001). In a mediation analysis, BDNF predicted mortality, with cortisol acting as the mediator (P = 0.011), yielding a mediation percentage of 29.92%. Mediation effects increased to 45.45% among younger patients. A BDNF*GRS interaction predicted mortality in younger patients (P = 0.004). Thus, we conclude 6-month mortality after severe TBI can be predicted through a mediation model with CSF cortisol and BDNF, suggesting a regulatory role for cortisol with BDNF's contribution to TBI pathophysiology and mortality, particularly among younger individuals with severe TBI. Based on the literature, cortisol modulated BDNF effects on mortality after TBI may be related to known hormone and neurotrophin relationships to neurological injury severity and autonomic nervous system imbalance
Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome
Neurofibromatosis type 1 (NF1) and Legius syndrome (LS) are caused by inactivating variants in NF1 and SPRED1. NF1 encodes neurofibromin (NF), a GTPase-activating protein (GAP) for RAS that interacts with the SPRED1 product, Sprouty-related protein with an EVH (Ena/Vasp homology) domain 1 (SPRED1). Obtaining a clinical and molecular diagnosis of NF1 or LS can be challenging due to the phenotypic diversity, the size and complexity of the NF1 and SPRED1 loci, and uncertainty over the effects of some NF1 and SPRED1 variants on pre-mRNA splicing and/or protein expression and function. To improve NF1 and SPRED1 variant classification and establish pathogenicity for NF1 and SPRED1 variants identified in individuals with NF1 or LS, we analyzed patient RNA by RT-PCR and performed in vitro exon trap experiments and estimated NF and SPRED1 protein expression, RAS GAP activity, and interaction. We obtained evidence to support pathogenicity according to American College of Medical Genetics guidelines for 73/114 variants tested, demonstrating the utility of functional approaches for NF1 and SPRED1 variant classification and NF and LS diagnostics.</p
ĐĐ°Đ±ĐŸĐ»Đ”ĐČĐ°ĐœĐžĐ” ŃĐ°Đ·ĐŸĐ±Đ”ĐŽŃĐ”ĐœĐœĐŸĐłĐŸ ŃŃŃŃĐ°ĐČĐ° Ń ĐŽĐ”ŃĐ”Đč Ń ĐœĐ°ŃлДЎŃŃĐČĐ”ĐœĐœĐŸĐč ĐżŃДЎŃĐ°ŃĐżĐŸĐ»ĐŸĐ¶Đ”ĐœĐœĐŸŃŃŃŃ: ĐșĐŸĐœŃДпŃŃĐ°Đ»ŃĐœĐ°Ń ĐŒĐŸĐŽĐ”Đ»Ń
ĐĐ° ĐŸŃĐœĐŸĐČĐ” ĐżŃĐžĐœŃĐžĐżĐŸĐČ ĐžĐœŃДгŃĐ°ŃĐžĐČĐœĐŸĐč ĐŒĐ”ĐŽĐžŃĐžĐœŃ, ŃĐžŃŃĐ”ĐŒĐœĐŸĐłĐŸ ĐżĐŸĐŽŃ
ĐŸĐŽĐ° Ń ĐžŃĐżĐŸĐ»ŃĐ·ĐŸĐČĐ°ĐœĐžĐ”ĐŒ ĐșĐŸĐœŃДпŃŃĐ°Đ»ŃĐœĐŸâĐ»ĐŸĐłĐžŃĐ”ŃĐșĐŸĐłĐŸ ĐŒĐŸĐŽĐ”Đ»ĐžŃĐŸĐČĐ°ĐœĐžŃ ŃĐ°Đ·ŃĐ°Đ±ĐŸŃĐ°ĐœĐ° Đ”ĐŽĐžĐœĐ°Ń ŃĐžŃŃĐ”ĐŒĐ° ĐżŃДЎŃŃĐ°ĐČĐ»Đ”ĐœĐžĐč ĐŸ Đ·Đ°Đ±ĐŸĐ»Đ”ĐČĐ°ĐœĐžŃŃ
ŃĐ°Đ·ĐŸĐ±Đ”ĐŽŃĐ”ĐœĐœĐŸĐłĐŸ ŃŃŃŃĐ°ĐČĐ° Ń ĐŽĐ”ŃĐ”Đč Ń ĐœĐ°ŃлДЎŃŃĐČĐ”ĐœĐœĐŸĐč ĐżŃДЎŃĐ°ŃĐżĐŸĐ»ĐŸĐ¶Đ”ĐœĐœĐŸŃŃŃŃ. ĐĐŸĐșĐ°Đ·Đ°ĐœĐŸ, ŃŃĐŸ ĐżŃĐ”ĐŽĐ»Đ°ĐłĐ°Đ”ĐŒŃĐč ĐžĐœŃДгŃĐ°ŃĐžĐČĐœŃĐč ĐżĐŸĐŽŃ
ĐŸĐŽ ĐŒĐŸĐ¶Đ”Ń ŃĐ»ŃжОŃŃ ĐŸŃĐœĐŸĐČĐŸĐč ĐŽĐ»Ń ŃĐ°Đ·ŃĐ°Đ±ĐŸŃĐșĐž ĐŽĐžĐ°ĐłĐœĐŸŃŃĐžŃĐ”ŃĐșĐžŃ
Đž ĐżŃĐŸĐłĐœĐŸŃŃĐžŃĐ”ŃĐșĐžŃ
ĐșŃĐžŃĐ”ŃОДĐČ ŃĐ°Đ·ĐČĐžŃĐžŃ ŃŃŃŃĐ°ĐČĐŸĐČ Đž ĐżŃĐŸĐČĐ”ĐŽĐ”ĐœĐžŃ ĐżĐ°ŃĐŸĐłĐ”ĐœĐ”ŃĐžŃĐ”ŃĐșĐŸĐłĐŸ Ń
ĐžŃŃŃгОŃĐ”ŃĐșĐŸĐłĐŸ лДŃĐ”ĐœĐžŃ, ĐœĐ°ĐżŃĐ°ĐČĐ»Đ”ĐœĐœĐŸĐłĐŸ ĐœĐ° лОĐșĐČОЎаŃĐžŃ ĐžĐ»Đž ŃŃŃĐ”ŃŃĐČĐ”ĐœĐœĐŸĐ” ŃĐœĐžĐ¶Đ”ĐœĐžĐ” ŃĐ°ŃŃĐŸŃŃ ŃĐŸŃĐŒĐžŃĐŸĐČĐ°ĐœĐžŃ ĐŽĐžŃплаŃŃĐžŃĐ”ŃĐșĐŸĐłĐŸ ĐșĐŸĐșŃĐ°ŃŃŃĐŸĐ·Đ°.Based on the principles of integrative medicine, systemic approach with the use of concept of logical modelling, a uniform system of concepts about the diseases of the hip joint in children with hereditary susceptibility was worked out. It was shown that the suggested integrative approach can be used for working out diagnostic and prognostic criteria of joint development and performing pathogenetic surgery aimed at elimination or reduction in the frequency of forming dysplastic coxarthrosis
Robust estimation of bacterial cell count from optical density
Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data
Recommended from our members
The bii4africa dataset of faunal and floral population intactness estimates across Africaâs major land uses
Sub-Saharan Africa is under-represented in global biodiversity datasets, particularly regarding the impact of land use on speciesâ population abundances. Drawing on recent advances in expert elicitation to ensure data consistency, 200 experts were convened using a modified-Delphi process to estimate âintactness scoresâ: the remaining proportion of an âintactâ reference population of a species group in a particular land use, on a scale from 0 (no remaining individuals) to 1 (same abundance as the reference) and, in rare cases, to 2 (populations that thrive in human-modified landscapes). The resulting bii4africa dataset contains intactness scores representing terrestrial vertebrates (tetrapods: ±5,400 amphibians, reptiles, birds, mammals) and vascular plants (±45,000 forbs, graminoids, trees, shrubs) in sub-Saharan Africa across the regionâs major land uses (urban, cropland, rangeland, plantation, protected, etc.) and intensities (e.g., large-scale vs smallholder cropland). This dataset was co-produced as part of the Biodiversity Intactness Index for Africa Project. Additional uses include assessing ecosystem condition; rectifying geographic/ taxonomic biases in global biodiversity indicators and maps; and informing the Red List of Ecosystems
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
INTRODUCTION
Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic.
RATIONALE
We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs).
RESULTS
Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants.
CONCLUSION
Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century
Analyse de l'uranium et du plutonium dans le cycle du combustible
SIGLEAvailable from INIST (FR), Document Supply Service, under shelf-number : RM 1625 / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc
- âŠ